DOR BioPharma Announces Publication Describing Protection Against Oral and Aerosol Ricin Exposure With Its Ricin Vaccine RiVax(TM)
MIAMI, FL -- 09/05/07 -- DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") announced today results from animal testing of RiVax(TM), its vaccine against ricin toxin, have been published online in the journal Vaccine, Smallshaw et al., "RiVax(TM), A Recombinant Ricin Subunit Vaccine, Protects Mice Against Ricin Given by Gavage or Aerosol"
Article: http://dx.doi.org/doi:10.1016/j.vaccine.2007.08.018
No comments:
Post a Comment